
AIM-9X production sits downstream of the broader munitions surge. The Trump supplemental allocated $21B for munitions stockpile increases across all platforms. If AIM-9X captures a meaningful slice of that envelope, Raytheon's Tucson line faces competition for skilled labor and fab time with THAAD production — which just secured a $35B multiyear contract to quadruple output from 96 to 400 units annually.
Both programs source common manufacturing expertise. A labor bottleneck at Tucson would force RTX to either delay one program or absorb restart costs at a second facility, neither of which appears in current guidance.
This contract operationalizes incremental capacity expansion in a mature air-to-air missile line, but the real constraint is not production authorization — it's whether Raytheon's Tucson facility can sustain the tooling and workforce required to scale beyond current rates.
The $1.1B commitment alone does not reveal production targets or delivery schedules, which determine whether this feeds near-term Taiwan Strait contingency munitions requirements or backfills peacetime inventory.
Watch the FY27 supplemental request (expected July-August) for whether DoD requests additional AIM-9X LRIP acceleration or treats this contract as sufficient to meet the 42-month munitions replenishment timeline outlined in the June 24 supplemental.
What are the annual unit targets embedded in this $1.1B award, and does the contract include options for Block III variants?
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.